Not a good buy right now: downside momentum is still building (bearish/expanding MACD) and the stock just broke below nearby support while heading into earnings.
With no Intellectia buy signals today and weakening fundamentals (revenue down YoY and losses widening), the risk/reward is unfavorable for an impatient entry.
Trend/momentum: MACD histogram is negative (-0.0151) and negatively expanding, signaling bearish momentum is strengthening.
RSI: RSI_6 at ~28.7 suggests the stock is near oversold conditions (bounce potential), but it’s not confirming a reversal by itself.
Moving averages: SMA_5 > SMA_20 > SMA_200 is a bullish MA stack, but price action is currently weak (today -5.49%), implying the MA signal may be lagging.
Levels: Current price 2.49 is below S1 (2.522) and below pivot (2.664); next support is S2 (2.435). Resistance levels to reclaim are ~2.66 (pivot) then ~2.81 (R1).
Pattern-based probabilities (similar candlesticks): slight negative bias near-term (next week expectation -0.74%), offering limited edge for an immediate buy.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning: Open interest put/call ratio of 0.18 is call-heavy (bullish tilt), but this can also reflect covered calls rather than outright bullish speculation.
Activity: Extremely low volume today (5 contracts total; put volume 5, call volume 0) makes sentiment signals unreliable.
Volatility: 30D IV ~79% vs historical vol ~54% suggests options are pricing elevated moves (earnings week effect). IV has been trending down vs 5D/10D averages, hinting that some event premium may already be moderating.
Technical Summary
Sell
0
Buy
12
Positive Catalysts
can support a short-term reflex bounce.
leans bullish on positioning (though not confirmed by volume).
Neutral/Negative Catalysts
and under nearby support (S1 2.522), indicating weak technical posture.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: 262.838M, down -1.31% YoY (soft top-line trend).
Net income: -24.691M, down -9.16% YoY (losses worsening).
EPS: -0.29, down -12.12% YoY (profitability deteriorating).
Overall: growth and profitability trends are negative into the upcoming earnings report, which reduces the attractiveness of buying immediately.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent change: Goldman Sachs (2026-01-19) downgraded to Neutral from Buy, lowering price target to EUR 13 from EUR 15, citing ongoing margin and sales pressure from a weaker consumer.
Wall Street pros view: brand/market positioning and potential cyclical recovery could improve results when housing activity strengthens.
Wall Street cons view: near-term demand/margins pressure and continued losses make timing riskier; downgrade suggests confidence has weakened.
Trading/flow context: Hedge funds and insiders are both described as Neutral (no strong accumulation signal). Politician/congress activity: no recent data.
Wall Street analysts forecast DOUG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DOUG is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast DOUG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DOUG is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Buy
Hold
Sell
0
Current: 2.600
Low
0
Averages
0
High
0
0
Current: 2.600
Low
0
Averages
0
High
0
Goldman Sachs
Buy
to
Neutral
downgrade
AI Analysis
2026-01-19
Reason
Goldman Sachs
Price Target
AI Analysis
2026-01-19
downgrade
Buy
to
Neutral
Reason
Goldman Sachs downgraded Douglas to Neutral from Buy with a price target of EUR 13, down from EUR 15. The company's preliminary Q1 results show ongoing margin and sales pressure from a weaker consumer, the analyst tells investors in a research note.